TB-500
Research recovery peptide name — not FDA-approved.
What it's for
TB-500 is a research/community name usually tied to thymosin beta-4 or related fragments studied for cell movement and tissue-repair ideas. It is not an FDA-approved drug product.
What it does for the body
It has been discussed for soft-tissue recovery and repair research. It is not approved to treat sports injuries or any disease in people. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Proposed ideas in early research include helping cells move to injury sites and supporting repair signaling (sometimes linked to actin-binding biology in thymosin beta-4). A simple picture: traffic directions for repair cells — still experimental.
Research context
Most publicly discussed work is early lab and animal or anecdotal; large controlled human trials are limited. Educational summaries only — not instructions for use.
Studied for (literature interest)
- Wound-healing and soft-tissue repair models (mostly preclinical)
- Interest in sports-medicine and recovery literature — limited human evidence
Cautions (educational)
- Not FDA-approved for any human indication.
- This encyclopedia does not provide dosing or sourcing.
Citations / starters
- PubMed search: TB-500 — NCBI PubMed
- ClinicalTrials.gov search: TB-500 — U.S. clinical trials registry
- FDA search: TB-500 — FDA.gov
- Drugs@FDA search: TB-500 — FDA drug database (if approved)
- OpenAlex works: TB-500 — Open scholarly index
Reference price
Ref $59 Reference only — not for sale Placeholder market reference for planning/display. DrPep does not sell peptides.
Add to cart · Coming soon